LRC Trial
Lipid Research Clinics(LRC) Primary Prevention Trial
Treatment with cholestyramine
19% reduction of combined fatal CAD and nonfatal MI
Total mortality was not reduced
Trend toward increased noncardiovascular deaths in the treatment group(especially suicides and violent deaths)